Paper1985208
Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvant.
Griffiths JC and 8 others. J Virol, 1991. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvant. Papers, record 1985208. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1985208
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvant.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| HIV | Major topic |
| HIV Antibodies | Major topic |
| HIV Envelope Protein gp120 | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Antibody Formation | |
| Base Sequence | |
| Binding Sites, Antibody | |
| Freund's Adjuvant | |
| Genetic Vectors | |
| Molecular Sequence Data | |
| Neutralization Tests | |
| Protein Conformation | |
| Rabbits |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3369091 | Envelope sequences of two new United States HIV-1 isolates. | Virology | 1988 | https://conductscience.org/library/papers/3369091 | PubMed |
| 2 | 1689753 | HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1. | J Immunol | 1990 | https://conductscience.org/library/papers/1689753 | PubMed |
| 3 | 2455898 | Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/2455898 | PubMed |
| 4 | 2457809 | Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans. | Nature | 1988 | https://conductscience.org/library/papers/2457809 | PubMed |
| 5 | 2458487 | Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1. | J Virol | 1988 | https://conductscience.org/library/papers/2458487 | PubMed |
| 6 | 2845130 | Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. | J Virol | 1988 | https://conductscience.org/library/papers/2845130 | PubMed |
| 7 | 2846691 | Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. | J Immunol | 1988 | https://conductscience.org/library/papers/2846691 | PubMed |
| 8 | 2851650 | Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses. | J Acquir Immune Defic Syndr (1988) | 1988 | https://conductscience.org/library/papers/2851650 | PubMed |
| 9 | 2540772 | An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. | AIDS | 1989 | https://conductscience.org/library/papers/2540772 | PubMed |
| 10 | 2469721 | Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. | J Immunol | 1989 | https://conductscience.org/library/papers/2469721 | PubMed |
| 11 | 2471813 | Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity. | J Gen Virol | 1989 | https://conductscience.org/library/papers/2471813 | PubMed |
| 12 | 2771954 | Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2771954 | PubMed |
| 13 | 2571187 | Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. | Science | 1989 | https://conductscience.org/library/papers/2571187 | PubMed |
| 14 | 2552068 | HIV-1 peptides induce a proliferative response in lymphocytes from infected persons. | J Acquir Immune Defic Syndr (1988) | 1989 | https://conductscience.org/library/papers/2552068 | PubMed |
| 15 | 3014647 | Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. | Science | 1986 | https://conductscience.org/library/papers/3014647 | PubMed |
| 16 | 3014663 | Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects. | Science | 1986 | https://conductscience.org/library/papers/3014663 | PubMed |
| 17 | 2431482 | HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. | Science | 1986 | https://conductscience.org/library/papers/2431482 | PubMed |
| 18 | 3466790 | Induction of anti-HIV neutralizing antibodies by synthetic peptides. | EMBO J | 1986 | https://conductscience.org/library/papers/3466790 | PubMed |
| 19 | 2438696 | Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/2438696 | PubMed |
| 20 | 3037522 | Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3037522 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36807845 | Gene-encoded nanoparticle vaccine platforms for in vivo assembly of multimeric antigen to promote adaptive immunity. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2023 | https://conductscience.org/library/papers/36807845 | PubMed |
| 16997714 | Virus-like particles: passport to immune recognition. | Methods | 2006 | https://conductscience.org/library/papers/16997714 | PubMed |
| 11725486 | Virus-like particles as vaccine adjuvants. | Mol Biotechnol | 2001 | https://conductscience.org/library/papers/11725486 | PubMed |
| 9420270 | Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1. | J Virol | 1998 | https://conductscience.org/library/papers/9420270 | PubMed |
| 8698376 | Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles. | Immunology | 1996 | https://conductscience.org/library/papers/8698376 | PubMed |
| 8497047 | Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion. | J Virol | 1993 | https://conductscience.org/library/papers/8497047 | PubMed |
| 8464405 | Pathogenesis of human immunodeficiency virus infection. | Microbiol Rev | 1993 | https://conductscience.org/library/papers/8464405 | PubMed |
| 7915974 | Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies. | Clin Exp Immunol | 1994 | https://conductscience.org/library/papers/7915974 | PubMed |
| 7769663 | Incorporation of pseudorabies virus gD into human immunodeficiency virus type 1 Gag particles produced in baculovirus-infected cells. | J Virol | 1995 | https://conductscience.org/library/papers/7769663 | PubMed |
| 2057382 | New nucleotide sequence data on the EMBL File Server. | Nucleic Acids Res | 1991 | https://conductscience.org/library/papers/2057382 | PubMed |
| 1548782 | Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primates. | J Virol | 1992 | https://conductscience.org/library/papers/1548782 | PubMed |
| 1433504 | Localization of an immunodominant domain on baculovirus-produced parvovirus B19 capsids: correlation to a major surface region on the native virus particle. | J Virol | 1992 | https://conductscience.org/library/papers/1433504 | PubMed |
| 1373205 | Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1. | J Virol | 1992 | https://conductscience.org/library/papers/1373205 | PubMed |
| 1362183 | Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles. | Immunology | 1992 | https://conductscience.org/library/papers/1362183 | PubMed |
Data10
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1985208
GET https://conductscience.org/api/papers/v1/1985208/references?page=2